Identification and Quantitation of

David Baliu-Rodriguez, Dorothy J You, Michael A Malfatti, Esther A Ubick, Yong Ho Kim, Bruce A Buchholz

Abstract read

In one paragraph

Article in Methods and protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

David Baliu-RodriguezBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA.

Dorothy J YouBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA.

Michael A MalfattiBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA.

Esther A UbickBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA.

Yong Ho KimRisk Assessment Support Division, Office of Mission Critical Operations, Office of Chemical Safety and Pollution Prevention, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA.ORCID 0000-0001-7527-0134

Bruce A BuchholzCenter for Accelerator Mass Spectrometry, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA.ORCID 0000-0002-9531-551X

Funding

National User Resource for Biological Accelerator Mass SpectrometryR24GM137748 · NIGMS · LAWRENCE LIVERMORE NATIONAL SECURITY, LLC · PI BENCH, GRAHAM · 2020 to 2024

$6.5M

LLNL-LDRD 23-ERD-020LLNL-LDRD 24-LW-026NIGMS NIH HHS R24 GM137748NIH HHS 5R24GM137748-05

6 · The paper itself

Abstract

The increasing frequency, duration, and intensity of wildfires over the past decade have raised significant concerns about widespread exposure to wildfire smoke. Inhalation of wildfire smoke poses a substantial risk to human health, with epidemiological studies linking exposure to cardiovascular, respiratory, and neurological dysfunction. Wildfire smoke contains hundreds of chemical compounds across diverse classes, with concentrations varying by fuel type and combustion conditions. Phenolic compounds are prominent constituents of wood smoke, and catechol is especially abundant under smoldering conditions that produce dense smoke. In this study,

Indexed as

accelerator mass spectrometryAMScarbon-14catecholLC-MSliquid chromatography-mass spectrometryPAMMSparallel accelerator and molecular mass spectrometrywildfirewood smoke extract

Identifiers

PMID41441190

DOI10.3390/mps8060147

PMCPMC12735648

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.